2526 HKG Week ended 07 Aug 2026

Weekly Investor Report

Hangzhou Diagens Biotechnology Co., Ltd. · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 418.0 HKD
29.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is - below the Trend Line and sits at 77.2% of its 52-week range. The latest completed week returned 29.1%, after a -8.7% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 36 out of 100
Latest Close 418.0 HKD 7 Aug 2026
1W Return 29.1% latest completed week
4W Return -8.7% short-term follow-through
12W Return 39.1% quarterly tape
Trend Breadth 0.0% 0 of 19 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 56.90% based on similar historical setup states.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 29.1% Latest completed week; four-week move -8.7%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.90% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 77.2% of its 52-week range. The latest completed week returned 29.1%, after a -8.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2312-week average 0.22

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.7% over four weeks, 39.1% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W29.1%
4W-8.7%
12W39.1%
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

2 positive · 2 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.5%Distance below the 52-week high.
13-week volatility20.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 187 weeks finished lower.
Best week+47.7%Week of 10 Jul.
Worst week-36.9%Week of 17 Jul.
Latest week+29.1%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains5
Flat weeks0
Modest losses1
Sharp losses6
Recent vol20.2%13-week weekly-return volatility.
Base vol18.4%52-week weekly-return volatility.
Up/down split11/7Count of positive and negative weeks in the 52-week window.
Average skew15.2% / -11.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis5/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.23; 4 reversal markers Next-Week ExpectancyPositive 56.90%

Next-week expectancy is positive with a 56.90% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

Hangzhou Diagens Biotechnology Announces Unaudited Interim Results for First Half of 2026 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026418.0 HKD29.1%-318.0 HKD0.00-219.8KOff
31 Jul 2026323.8 HKD20.4%-312.5 HKD0.00-225.0KOff
24 Jul 2026269.0 HKD-6.9%-311.8 HKD0.00-282.7KOff
17 Jul 2026288.8 HKD-36.9%-314.5 HKD0.00-285.6KOff
10 Jul 2026458.0 HKD47.7%-316.2 HKD0.00-576.7KOff
3 Jul 2026310.0 HKD3.7%-306.1 HKD0.00-51.1KOff
26 Jun 2026299.0 HKD-3.4%-305.8 HKD0.00-13.6KOff
19 Jun 2026309.6 HKD-4.9%-306.3 HKD0.00-319.2KOff
12 Jun 2026325.4 HKD3.3%-306.0 HKD0.00-24.2KOff
5 Jun 2026315.0 HKD-11.3%-304.1 HKD0.00-107.0KOff
29 May 2026355.0 HKD1.4%-302.9 HKD0.00-601.4KOff
22 May 2026350.0 HKD16.4%-296.4 HKD0.00-756.1KOff
15 May 2026300.6 HKD-8.9%-288.7 HKD0.00-1.2MOff
8 May 2026330.0 HKD14.6%-286.7 HKD0.00-847.0KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context